Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression

the REAL‐ESK Study Group, Giovanni Martinotti, Bernardo Dell'Osso, Giorgio Di Lorenzo, Giuseppe Maina, Alessandro Bertolino, Massimo Clerici, Stefano Barlati, Gianluca Rosso, Marco Di Nicola, Matteo Marcatili, Giacomo d'Andrea, Clara Cavallotto, Stefania Chiappini, Sergio De Filippis, Giuseppe Nicolò, Pasquale De Fazio, Ileana Andriola, Raffaella Zanardi, Domenica NuciforaStefania Di Mauro, Roberta Bassetti, Mauro Pettorruso, Roger S. McIntyre, Stefano L. Sensi, Massimo di Giannantonio, Antonio Vita, Giulia Baldacci, Sandro Belletti, Antonello Bellomo, Beatrice Benatti, Matteo Carminati, Rosalba Carullo, Domenico de Berardis, Renato de Filippis, Roberto Delle Chiaie, Francesco di Carlo, Gilberto Di Petta, Alessandro Galluzzo, Valentina Giorgelli, Ginevra Lombardozzi, Vassilis Martiadis, Chiara Mattei, Alessio Mosca, Cinzia Niolu, Miriam Olivola, Mauro Percudani, Maria Pepe, Eros Rossi, Maria Ilaria Scardigli, Filippo Tatì

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression'. Together they form a unique fingerprint.

Medicine & Life Sciences